Evidence map›Paper›PMID 40620655›Full record

ArticleCentral-European journal of immunology2025

Role of

Karzan Abdulmuhsin Mohammad, Hero M Ismael, Shukur Wasman Smail, Taban Kamal Rasheed, Mohammed O Rahman, Niaz Albarzinji, Rebaz Hamza Salih, Kalthum Othman Taha, Khawlah Salah KHAleel, Kawa Amin and 1 more

Abstract read
In one paragraph

Article in Central-European journal of immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Karzan Abdulmuhsin MohammadDepartment of Biology, College of Science, Salahaddin University-Erbil, Erbil, Kurdistan Region, Iraq.
Hero M IsmaelDepartment of Biology, College of Science, Salahaddin University-Erbil, Erbil, Kurdistan Region, Iraq.
Shukur Wasman SmailDepartment of Biology, College of Science, Salahaddin University-Erbil, Erbil, Kurdistan Region, Iraq.
Taban Kamal RasheedDepartment of Biology, College of Science, Salahaddin University-Erbil, Erbil, Kurdistan Region, Iraq.
Mohammed O RahmanDepartment of Medical Microbiology, College of Science, Cihan University-Erbil, Kurdistan Region, Iraq.
Niaz AlbarzinjiCollege of Medicine, Hawler Medical University, Erbil, Iraq.
Rebaz Hamza SalihPAR Private Hospital, Erbil, Kurdistan Region, Iraq.
Kalthum Othman TahaDepartment of Biology, College of Science, Salahaddin University-Erbil, Erbil, Kurdistan Region, Iraq.
Khawlah Salah KHAleelDepartment of Biology, College of Science, Salahaddin University-Erbil, Erbil, Kurdistan Region, Iraq.
Kawa AminDepartment of Medical Science, Respiratory, Allergy and Sleep Research, Uppsala University and University Hospital, Uppsala, Sweden.
Christer JansonDepartment of Medical Science, Respiratory, Allergy and Sleep Research, Uppsala University and University Hospital, Uppsala, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The progression of fungal co-infection with COVID-19 depends on the patient's genetic innate immunity. Our goal is to understand the connection between the single nucleotide polymorphisms (SNPs) rs5743708 and rs16910526 in the toll-like receptor 2 (TLR2) and dectin-1 (CLEC7A) genes, respectively, and fungal infection in COVID-19 patients. Material and methods: This study assessed the SNPs rs5743708 from the TLR2 gene and rs16910526 from dectin-1 by Sanger sequencing. Two groups of COVID-19 patients participated in this study: 110 COVID-19 patients free from fungal infection (COVID-19 FFI), and 77 COVID-19 patients with fungal infection (COVID-19 WFI). Results: The AG genotype of the TLR2 SNP rs5743708 showed no significant association with fungal infection in COVID-19 compared to the AA genotype. However, the GG genotype and G allele were significantly associated with decreased vulnerability to fungal co-infections. Similarly, regarding the dectin-1 SNP rs16910526, the TG genotype did not show a significant association with fungal infection compared to the TT genotype, but the GG genotype and G allele were significantly related to decreased susceptibility to fungal co-infections in COVID-19. The TLR2 protein levels in the serum of COVID-19 patients with GG genotypes of TLR2 rs5743708 were elevated. Variations in the dectin-1 genotypes (specifically GG genotype) can also raise the levels of dectin-1 serum protein. Conclusions: The relationship between TLR2 rs5743708 and dectin-1 rs16910526 SNPs and susceptibility to fungal infection in COVID-19 patients was found to be significant, highlighting the im- portance of investigating their connection to infection progression for personalized patient care. The variation in genotypes also affects the levels of corresponding serum TLR2 and dectin-1.

Indexed as

COVID-19dectin-1fungal coinfectionpolymorphismsusceptibilityTLR2

Identifiers

PMID40620655
PMCPMC12224246

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.